SGEF enhances EGFR stability through delayed EGFR trafficking from early to late endosomes

Hongtao Wang, Shanhu Li, Hailiang Li, Changling Li, Kaopeng Guan, Guolan Luo, Lan Yu, Ruiqin Wu, Xiaoqing Zhang, Jian Wang, Jianguang Zhou

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Previously, we demonstrated an elevated SH3-containing guanine nucleotide exchange factor (SGEF) expression in clinical specimens with prostate cancer and implicated the role of SGEF in prostate tumorigenesis. However, the molecular mechanism behind the SGEF regulation of prostate cancer development is not known. In this study, we show that SGEF expression delays epidermal growth factor receptor (EGFR) degradation in prostate cancer cells and is independent from its guanine nucleotide exchange factor (GEF) function. We further show that the delayed degradation is due to a delay in EGFR trafficking from early to late endosomes and not to a decrease in EGFR ubiquitination. Finally, we show that depletion of SGEF significantly inhibits epidermal growth factor-induced EGFR signaling cascade and cell migration in the prostate cancer cells. We report for the first time an SGEF function for RhoG that excludes GEF and the ability of SGEF to enhance EGFR stability and signaling by delaying its lysosomal sorting and degradation. This could be one mechanism by which SGEF contributes to prostate cancer progression.

Original languageEnglish (US)
Pages (from-to)1976-1983
Number of pages8
JournalCarcinogenesis
Volume34
Issue number9
DOIs
StatePublished - Sep 1 2013
Externally publishedYes

Fingerprint

Guanine Nucleotide Exchange Factors
Endosomes
Epidermal Growth Factor Receptor
Prostatic Neoplasms
Ubiquitination
Epidermal Growth Factor
Cell Movement
Prostate
Carcinogenesis

ASJC Scopus subject areas

  • Cancer Research

Cite this

Wang, H., Li, S., Li, H., Li, C., Guan, K., Luo, G., ... Zhou, J. (2013). SGEF enhances EGFR stability through delayed EGFR trafficking from early to late endosomes. Carcinogenesis, 34(9), 1976-1983. https://doi.org/10.1093/carcin/bgt157

SGEF enhances EGFR stability through delayed EGFR trafficking from early to late endosomes. / Wang, Hongtao; Li, Shanhu; Li, Hailiang; Li, Changling; Guan, Kaopeng; Luo, Guolan; Yu, Lan; Wu, Ruiqin; Zhang, Xiaoqing; Wang, Jian; Zhou, Jianguang.

In: Carcinogenesis, Vol. 34, No. 9, 01.09.2013, p. 1976-1983.

Research output: Contribution to journalArticle

Wang, H, Li, S, Li, H, Li, C, Guan, K, Luo, G, Yu, L, Wu, R, Zhang, X, Wang, J & Zhou, J 2013, 'SGEF enhances EGFR stability through delayed EGFR trafficking from early to late endosomes', Carcinogenesis, vol. 34, no. 9, pp. 1976-1983. https://doi.org/10.1093/carcin/bgt157
Wang, Hongtao ; Li, Shanhu ; Li, Hailiang ; Li, Changling ; Guan, Kaopeng ; Luo, Guolan ; Yu, Lan ; Wu, Ruiqin ; Zhang, Xiaoqing ; Wang, Jian ; Zhou, Jianguang. / SGEF enhances EGFR stability through delayed EGFR trafficking from early to late endosomes. In: Carcinogenesis. 2013 ; Vol. 34, No. 9. pp. 1976-1983.
@article{75a726f5f56049b8ad0636c0ee9ddc63,
title = "SGEF enhances EGFR stability through delayed EGFR trafficking from early to late endosomes",
abstract = "Previously, we demonstrated an elevated SH3-containing guanine nucleotide exchange factor (SGEF) expression in clinical specimens with prostate cancer and implicated the role of SGEF in prostate tumorigenesis. However, the molecular mechanism behind the SGEF regulation of prostate cancer development is not known. In this study, we show that SGEF expression delays epidermal growth factor receptor (EGFR) degradation in prostate cancer cells and is independent from its guanine nucleotide exchange factor (GEF) function. We further show that the delayed degradation is due to a delay in EGFR trafficking from early to late endosomes and not to a decrease in EGFR ubiquitination. Finally, we show that depletion of SGEF significantly inhibits epidermal growth factor-induced EGFR signaling cascade and cell migration in the prostate cancer cells. We report for the first time an SGEF function for RhoG that excludes GEF and the ability of SGEF to enhance EGFR stability and signaling by delaying its lysosomal sorting and degradation. This could be one mechanism by which SGEF contributes to prostate cancer progression.",
author = "Hongtao Wang and Shanhu Li and Hailiang Li and Changling Li and Kaopeng Guan and Guolan Luo and Lan Yu and Ruiqin Wu and Xiaoqing Zhang and Jian Wang and Jianguang Zhou",
year = "2013",
month = "9",
day = "1",
doi = "10.1093/carcin/bgt157",
language = "English (US)",
volume = "34",
pages = "1976--1983",
journal = "Carcinogenesis",
issn = "0143-3334",
publisher = "Oxford University Press",
number = "9",

}

TY - JOUR

T1 - SGEF enhances EGFR stability through delayed EGFR trafficking from early to late endosomes

AU - Wang, Hongtao

AU - Li, Shanhu

AU - Li, Hailiang

AU - Li, Changling

AU - Guan, Kaopeng

AU - Luo, Guolan

AU - Yu, Lan

AU - Wu, Ruiqin

AU - Zhang, Xiaoqing

AU - Wang, Jian

AU - Zhou, Jianguang

PY - 2013/9/1

Y1 - 2013/9/1

N2 - Previously, we demonstrated an elevated SH3-containing guanine nucleotide exchange factor (SGEF) expression in clinical specimens with prostate cancer and implicated the role of SGEF in prostate tumorigenesis. However, the molecular mechanism behind the SGEF regulation of prostate cancer development is not known. In this study, we show that SGEF expression delays epidermal growth factor receptor (EGFR) degradation in prostate cancer cells and is independent from its guanine nucleotide exchange factor (GEF) function. We further show that the delayed degradation is due to a delay in EGFR trafficking from early to late endosomes and not to a decrease in EGFR ubiquitination. Finally, we show that depletion of SGEF significantly inhibits epidermal growth factor-induced EGFR signaling cascade and cell migration in the prostate cancer cells. We report for the first time an SGEF function for RhoG that excludes GEF and the ability of SGEF to enhance EGFR stability and signaling by delaying its lysosomal sorting and degradation. This could be one mechanism by which SGEF contributes to prostate cancer progression.

AB - Previously, we demonstrated an elevated SH3-containing guanine nucleotide exchange factor (SGEF) expression in clinical specimens with prostate cancer and implicated the role of SGEF in prostate tumorigenesis. However, the molecular mechanism behind the SGEF regulation of prostate cancer development is not known. In this study, we show that SGEF expression delays epidermal growth factor receptor (EGFR) degradation in prostate cancer cells and is independent from its guanine nucleotide exchange factor (GEF) function. We further show that the delayed degradation is due to a delay in EGFR trafficking from early to late endosomes and not to a decrease in EGFR ubiquitination. Finally, we show that depletion of SGEF significantly inhibits epidermal growth factor-induced EGFR signaling cascade and cell migration in the prostate cancer cells. We report for the first time an SGEF function for RhoG that excludes GEF and the ability of SGEF to enhance EGFR stability and signaling by delaying its lysosomal sorting and degradation. This could be one mechanism by which SGEF contributes to prostate cancer progression.

UR - http://www.scopus.com/inward/record.url?scp=84886999489&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886999489&partnerID=8YFLogxK

U2 - 10.1093/carcin/bgt157

DO - 10.1093/carcin/bgt157

M3 - Article

C2 - 23661635

AN - SCOPUS:84886999489

VL - 34

SP - 1976

EP - 1983

JO - Carcinogenesis

JF - Carcinogenesis

SN - 0143-3334

IS - 9

ER -